Therapeutics, Inc Share Price Today: Live Updates & Key Insights

Therapeutics, Inc share price today is $10.9, up -8.79%. The stock opened at $11.36 against the previous close of $11.49, with an intraday high of $11.47 and low of $10.445.

Therapeutics, Inc Share Price Chart

Therapeutics, Inc

us-stock
To Invest in {{usstockname}}
us-stock

Therapeutics, Inc Share Price Performance

$10.9 -0.0879(-8.79%) LENZ at 23 Mar 2026 01:56 PM Biotechnology
Lowest Today 10.445
Highest Today 11.47
Today’s Open 11.36
Prev. Close 11.49
52 Week High 50.40
52 Week Low 10.44
Day’s Range: Low 10.445 High 11.47
52-Week Range: Low 10.44 High 50.40
1 day return -
1 Week return -11.04
1 month return -11.94
3 month return -40.61
6 month return -74.63
1 year return -60.87
3 year return -5.6
5 year return -88.06
10 year return -

Therapeutics, Inc Institutional Holdings

Therapeutics, Inc Market Status

Strong Buy: 5

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Therapeutics, Inc Fundamentals

Market Cap 327.92 M

PB Ratio 1.8539

PE Ratio 0.0

Enterprise Value 158.30 M

Total Assets 215.30 M

Volume 1528901

Therapeutics, Inc Company Financials

Annual Revenue FY23:null 0.0M

Annual Profit FY23:-2407000 -2.4M

Annual Net worth FY23:-124651000 -124.7M

Quarterly Revenue Q3/2025:12500000 12.5M, Q2/2025:5000000 5.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:12375000 12.4M, Q2/2025:5000000 5.0M, Q1/2025:-36000 -0.0M, Q3/2024:-10000 -0.0M, Q2/2024:-18000 -0.0M

Quarterly Net worth Q3/2025:-16700000 -16.7M, Q2/2025:-14912000 -14.9M, Q1/2025:-14619000 -14.6M, Q3/2024:-10215000 -10.2M, Q2/2024:-10254000 -10.3M

About Therapeutics, Inc & investment objective

Company Information LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

Organisation Biotechnology

Employees 0

Industry Biotechnology

CEO Mr. Evert B. Schimmelpennink

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Therapeutics, Inc FAQs

What is the share price of Therapeutics, Inc today?

The current share price of Therapeutics, Inc is $10.9.

Can I buy Therapeutics, Inc shares in India?

Yes, Indian investors can buy Therapeutics, Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Therapeutics, Inc shares in India?

You can easily invest in Therapeutics, Inc shares from India by:

Can I buy fractional shares of Therapeutics, Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Therapeutics, Inc?

Therapeutics, Inc has a market cap of $327.92 M.

In which sector does Therapeutics, Inc belong?

Therapeutics, Inc operates in the Biotechnology sector.

What documents are required to invest in Therapeutics, Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Therapeutics, Inc?

The PE ratio of Therapeutics, Inc is N/A and the PB ratio is 1.85.